-
Rene Eyre Revisits Autobiographical Performance 'Say A Little Prayer' in London
-
London Museum Granted 24/7 License Ahead of November Opening
-
UAE's HCT Holds Record Graduation and Announces Major Training Expansion
-
Dana White Confirms Flight to Washington for Trump Meeting on Press Secretary Role
-
NASA Awards $10B Lunar Contract Framework to SpaceX, Blue Origin
-
Dengue Fever Expands Into High Himalayas as Climate Change Warms Nepal
-
Katy Perry Tells Fans Ex-Husband Russell Brand 'Should Be in Jail' During UK Concert
-
IoT Refrigerator Hacks Disrupt Blood Labs and Supermarkets Across Europe and US
-
South African election results renew debate over identity-based voting
-
Post-election pressures complicate US and Israeli decisions on Iran
-
South African voters report smoother local election but declining IEC trust
-
UN members approve talks on treaty protocol against environmental crime
-
Dolly Parton museum and Nashville hotel open after singer’s death
-
Family-run West Sussex beach café prepares for first winter season
-
George and Amal Clooney attend New York political-comedy reading
-
CT scans reveal health and burial clues from Egypt’s Braided Lady mummy
-
British buyers pay substantial premiums for period-home appearance
-
Oxford faces complaints over lecturer’s classroom attire
-
Thomas Markle released to house arrest after child-abuse-image charge
Featured
Last news
LiberNovo 2026 Triple Launch: SE, Pro, and Maxis Deliver Dynamic Ergonomics for Every Body Type
HONG KONG, HK / ACCESS Newswire / May 18, 2026 / LiberNovo, the premium ergonomic chair brand redefining how people sit, today unveiled the full scope of its 2026 product expansion: three distinct lines engineered to bring Dynamic Ergonomics to a far wider range of users. The Omni SE, Omni Pro, and all-new Maxis series will officially launch on June 16, with deposit-based pre-orders now open to U.S. customers.
Aytu BioPharma to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
DENVER, CO / ACCESS Newswire / May 18, 2026 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2026 Investor Conference, taking place virtually on Thursday, May 28, 2026.
Watson's Accelerates Strategic Growth with Acquisition of Viridien Patio + Fireplace, Strengthening Southern U.S. Presence
##
Fire Help Center Urges Families to Have a Wildfire Plan in Place Before Memorial Day Weekend
With Oregon's 2026 wildfire season already underway and human activity responsible for 20% of the state's fires, experts warn that the holiday weekend is one of the highest-risk periods of the year.
Sunshine Biopharma Inc. Announces Pricing of $6.0 Million Public Offering
FORT LAUDERDALE, FL / ACCESS Newswire / May 18, 2026 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a pharmaceutical company offering and developing life‑saving medicines across oncology, antivirals, and other key therapeutic areas, today announced the pricing of a public offering made on a reasonable best efforts basis with gross proceeds to the Company expected to be approximately $6.0 million, before deducting placement agent fees and other offering expenses payable by the Company.
Europe's Healthcare IT Market Enters the 2027 Readiness Cycle as Black Book Names 26 Top Client-Rated Vendors During HIMSS26 Week in Copenhagen
Category-specific honors identify client-rated leaders in data-ready EHRs, interoperability, enterprise imaging, cloud, cybersecurity, AI, advisory, analytics, clinical decision support and digital health infrastructure
Trustpoint Xposure Expands AEO Services to Include AI Chatbot Authority Strategy, Helping Brands Get Cited Inside the AI Assistants Their Clients Use Every Day
New service tier addresses the fastest-growing discovery channel in professional services, the AI chatbot query, with a methodology built to make clients the answer conversational AI recommends
Ebola Global Health Emergency Needs a Broad-Spectrum Drug - NV-387 is a Strong Potential Candidate, Says NanoViricides
SHELTON, CT / ACCESS Newswire / May 18, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing antiviral drugs that viruses cannot escape, emphasizes the critical need for a revolutionary, broad-spectrum, antiviral drug like NV-387 as another severe Ebolavirus outbreak has occurred in the Eastern part of DR Congo (DRC), with spillage across the border into Uganda.
June 29 Marijuana Rescheduling Hearing Faces Constitutional Issues Before It Even Begins
MMJ BioPharma Cultivation Exposed a Fundamental Constitutional Defect Inside the DEA. Now the Same Defective Administrative System Is Expected to Handle the Most Consequential Drug Rule making in a Generation.The DEA's Marijuana Rescheduling Problem: The Government Admitted the Judge System Is Unconstitutional - So Who Is Supposed To Run the Hearings?
InterContinental Hotels Group PLC Announces Transaction in Own Shares - May 18
Purchase of own shares
UK police detail arrests after far-right rally and counter demo
London police said Sunday officers arrested 20 people the previous day at a march organised by far-right activist Tommy Robinson and 12 people at a counter-demonstration fused with a pro-Palestinian protest.
Italian PM meets victims of Modena car incident
Italian Prime Minister Giorgia Meloni on Sunday visited people wounded by a driver with a history of mental health problems who ran over several pedestrians in a city centre in northern Italy.
Eyewitness says Modena tragedy could have been even worse
Still reeling from witnessing a car ploughing through a crowded city centre in Modena in northern Italy on Saturday, pensioner Walter Botorsi said an even bigger tragedy had been narrowly avoided.
Probes ongoing into alleged abuse at 84 Paris preschools: prosecutor
Paris investigators are looking into allegations non-teaching staff recruited by the city mistreated or abused children at 84 kindergartens and around 20 primary schools, a prosecutor said Sunday.
'Geek' hangout to tourist draw: Japan's maid cafes
"Master, mistress -- welcome home!" exclaims the smiling young woman in a French maid's costume, as customers pass through the looking glass into a unique Japanese world with oodles of quirkiness, cuteness and cake.
Venezuela expels Maduro ally Alex Saab to US again
Former Venezuelan industry minister Alex Saab, a close ally of deposed president Nicolas Maduro, was expelled to the United States on Saturday for a second time, Venezuelan officials said.
Maldives rescue diver dies in search for missing Italians
A rescue diver in the Maldives searching for the bodies of four Italians, who drowned in the deadliest diving disaster in the Indian Ocean tourist destination, has also died, authorities said Saturday.
State Cannabis Companies Rushed To Apply for DEA Registration but DEA Cannot Rewrite Marijuana Federal Register Rules With a Press Statement
"DEA Told Cannabis Companies Federal Compliance Mattered - Now the Companies That Ignored the Rules Want Fast Entry Into the Same Federal System" stated Duane Boise CEO MMJ International Holdings.
Europe's Hospital Cyber Risk Has Moved From Data Theft to Care Disruption, Black Book Study Warns Ahead of HIMSS26 Europe
Pre-HIMSS26 Copenhagen survey of 284 European hospital cybersecurity buyers finds 82% report very high or extreme attack concern as demand shifts to clinical continuity, identity resilience, ransomware recovery, and supplier-risk protection
US says Iran-backed militia commander planned Jewish site attacks
US authorities on Friday detailed charges against a commander of an Iran-backed Iraqi militia who was allegedly involved in plotting terrorism against Jewish people in Europe, Canada and the United States.
Judge declares mistrial in Weinstein case as jury fails to reach verdict
A US judge declared a mistrial in the trial of disgraced cinema mogul Harvey Weinstein after jurors again failed to reach a verdict on allegations he sexually assaulted actor Jessica Mann, prosecutors said.
Germany's Merz says wouldn't advise young people to move to US
German Chancellor Friedrich Merz said Friday he would not advise young people in his country to move to the United States for study or work, in the latest sign of cooling ties between Berlin and Washington.
Civilians caught in war of drones in eastern DR Congo
In the eastern Democratic Republic of Congo, a conflict that drags on despite peace talks has taken a dangerous new turn, with civilians now struck from the air by drones, far from the front line.
French city reels from teen killing in drug-linked shooting
Shooters have killed a 15-year-old in France's western city of Nantes in a suspected score-settling incident linked to drugs, a prosecutor said.
Indian magnate Adani agrees multi-million-dollar penalty in US court case
Indian billionaire industrialist Gautam Adani has agreed to pay a multi-million-dollar settlement in a US civil court case linked to corruption without admitting guilt, his company said Friday.
Bitter church row divides Armenia ahead of elections
Walking through the grounds of Armenia's most sacred church, 37-year-old worshipper Nara Sargsyan spoke in hushed tones as she criticised her government's attacks on the clergy.
Malaysia PM says not opposed to fugitive financier's bid for pardon
Malaysia will not oppose a bid by a fugitive businessman involved in the massive 1MDB corruption scandal to seek a pardon from US President Donald Trump, Prime Minister Anwar Ibrahim said Friday.
Letter to the Shareholders
LAKEWOOD, CO / ACCESS Newswire / May 15, 2026 / Kultura Brands, Inc. (OTCID:LTNC) ("Kultura Brands," "Kultura," or the "Company"), formerly known as Labor Smart INC., a publicly traded consumer products and lifestyle platform focused on scaling culture-driven beverage brands.
Onco-Innovations Strengthens Quality Testing for Lead PNKP Inhibitor Drug Candidate
VANCOUVER, BC / ACCESS Newswire / May 15, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:W1H)(WKN: A3EKSZ) ("Onco" or the "Company") is pleased to announce that it has advanced its Chemistry, Manufacturing and Controls ("CMC") development program through the initiation of analytical method validation activities for assay, related substances, and residual solvents for A83B4C63, the active pharmaceutical ingredient ("API") for Onco's exclusively-licensed PNKP Inhibitor Technology, ONC010. These validation activities are designed to ensure the Company can consistently measure what is in the drug, confirm it meets quality standards, and demonstrate that manufacturing is reliable, all of which are important steps before a program can move toward future clinical trials.
Luvu Brands Reports Strong Q3 FY26 Results with 12% Revenue Growth, Margin Expansion, and Improved Profitability Driven by Disciplined Cost Management
ATLANTA, GA / ACCESS Newswire / May 15, 2026 / Luvu Brands, Inc. (OTCQB:LUVU), a U.S.-based manufacturer of lifestyle, wellness, and comfort products, today announced financial results for its third fiscal quarter ended March 31, 2026. The Company delivered meaningful improvements in revenue, profitability, and cash generation, reflecting continued execution of its cost optimization strategy and operational discipline.
Ensysce Biosciences Reports First Quarter 2026 Financial Results
~ IRB Approval Secured for PF614-MPAR-102 Part 3 ~~ Clinical Peer-Reviewed Data Published for First Overdose Protected Opioid PF614-MPAR®; Patent Estate Expanded ~~ Company Launches Formal Review of Strategic Alternatives ~
Havertys Furniture Second Quarter 2026 Cash Dividend
ATLANTA, GA / ACCESS Newswire / May 15, 2026 / Haverty Furniture Companies, Inc. (NYSE:HVT)(NYSE:HVT.A) ("Havertys" or the "Company") today announced that its Board of Directors declared a cash dividend to be paid on the outstanding shares of the two classes of $1 par value common stock of the company at a rate of $0.33 per share on the common stock and $0.31 per share on the Class A common stock. The dividend is payable on June 16, 2026, to stockholders of record at the close of business on June 1, 2026. Havertys has paid a cash dividend each year since 1935.